S
Shuhua Tian
Publications - 6
Citations - 412
Shuhua Tian is an academic researcher. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 2, co-authored 2 publications receiving 172 citations.
Papers
More filters
Journal ArticleDOI
Petroleum Hydrocarbon-Degrading Bacteria for the Remediation of Oil Pollution Under Aerobic Conditions: A Perspective Analysis.
Xingjian Xu,Wenming Liu,Shuhua Tian,Wei Wang,Qige Qi,Pan Jiang,Xinmei Gao,Fengjiao Li,Haiyan Li,Haiyan Li,Hongwen Yu,Hongwen Yu +11 more
TL;DR: An overview of the recent literature referring to the usage of bacteria as biodegraders is provided, barriers regarding the implementation of this microbial technology are discussed, and suggestions for further developments are provided.
Journal ArticleDOI
Potential biodegradation of phenanthrene by isolated halotolerant bacterial strains from petroleum oil polluted soil in Yellow River Delta.
Xingjian Xu,Wenming Liu,Wei Wang,Shuhua Tian,Pan Jiang,Qige Qi,Fengjiao Li,Haiyan Li,Quan-Ying Wang,Huai Li,Hongwen Yu +10 more
TL;DR: This project not only obtained two halotolerant petroleum hydrocarbon degraders but also provided a promising remediation approach for solving oil pollutants in salinity environments.
Journal ArticleDOI
Combating biofilms of foodborne pathogens with bacteriocins by lactic acid bacteria in the food industry.
Xinyi Pang,Xiaoye Song,Minjie Chen,Shuhua Tian,Zhaoxin Lu,Jing Sun,Xiangfei LiX. Li,Ying-Yuh Lu,Hyun-Gyun Yuk +8 more
TL;DR: The findings indicate that bacteriocins can effectively inhibit biofilm formation in a dose-dependent manner, but are difficult to disrupt preformed biofilms.
Journal ArticleDOI
Broccoli microgreens have hypoglycemic effect by improving blood lipid and inflammatory factors while modulating gut microbiota in mice with type 2 diabetes.
TL;DR: It is proved that broccoli microgreens have the ability to regulate type 2 diabetes and improve symptoms of mice T2D induced by high-fat diet and streptozotocin (STZ).
Journal ArticleDOI
Shared signaling pathways and targeted therapy by natural bioactive compounds for obesity and type 2 diabetes.
TL;DR: In this paper , a comprehensive information of the commonly shared signaling pathways between obesity and T2DM, and also summarize the therapeutic bioactive compounds that may serve as anti-obesity and/or anti-diabetes therapeutics by regulating these associated pathways, which contribute to improving glucose and lipid metabolism, attenuating inflammation.